NMNH is dephosphorylated into NRH to be transported into the cell through equilibrative nucleoside transporters (ENTs) 35 , where it is phosphorylated back into NMNH by adenosine kinase (AK) 36
Zhou YQ, Chen SY, Wang JY (2009) Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy
Certificate Of Analysis 1
Clinical risks include nausea, vomiting, raised heart rate, and potential hypoglycaemia if used alongside diabetes medications, all without any medical supervision or quality assurance
Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein
Diabetologia 44 , 129146 (2001)